RESITU
Live / Applied — Fourth extension granted (statement of use) (as of 06 Mar 2026)
What this means for you
Not registered yet, but its 19 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97638782
- Mark type
- Stylized text
- Filed
- 19 Oct 2022
- Published for opposition
- 16 Jan 2024
- Attorney of record
- David L. May
Goods and services
- Class 010 — Medical apparatus: Medical apparatus, instruments and devices for sampling of tissue from human breast and surgical apparatus, instruments and devices intended for use inside the human body; medical apparatus, instruments and devices, namely, a biopsy device for sampling of tissue from human breast and surgical apparatus, instruments and devices to be used in connection with medical procedures; Apparatus for taking biopsies of the human breast for tumour diagnosis; Ultrasonic medical diagnostic apparatus; Ultrasonic sensors for medical use; Apparatus for the treatment of cancer, namely, ultrasound guided devices used for the treatment of cancer; Biopsy needles; Biopsy devices
- Class 042 — Scientific and technological services: Research and development services in the field of engineering
Owner
- Resitu Medical AB, Uppsala, SE
- Resitu Medical AB, Uppsala, SE
Prosecution history
- 09 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 07 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Mar 2026 — SOU EXTENSION 4 GRANTED
- 06 Mar 2026 — SOU EXTENSION 4 FILED
- 06 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2025 — SOU EXTENSION 3 GRANTED
- 03 Sept 2025 — SOU EXTENSION 3 FILED
- 03 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2025 — SOU EXTENSION 2 GRANTED
- 12 Mar 2025 — SOU EXTENSION 2 FILED
- 12 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Aug 2024 — SOU EXTENSION 1 GRANTED